Authors



Samantha Gorski, PharmD Candidate

Latest:

To Understand Human Disorders, Researchers Look to Man’s Best Friend

Explore the intriguing connections between bulldogs and human medical conditions, revealing insights into congenital disorders and their treatments.


Skylar Kenney, Assistant Editor

Latest:

Study: Abortions Remain Safe Following Lifted Restrictions on Mifepristone

The study examined government health data on 315,000 abortions in Ontario between 2012 and 2020, finding no increase in abortion-related health complications following the removal of restrictions on mifepristone.


Erin Hunter, Associate Editor

Latest:

Environmental Toxin BPA Affects Gut Microbial Communities in Children

Children with normal weight had different community relationships compared to children with overweight or obesity.


Jill Murphy, Associate Editor

Latest:

Data Analysis Shows Significant New Onset Morbidity Post-COVID-19 in Children, Adolescents, Adults

Although long-term health issues from COVID-19 are a major public health concern, evidence on post-COVID-19 symptoms are still limited, specifically among children and adolescents.


Alana Hippensteele, Managing Editor

Latest:

FDA Grants EUA for Vilobelimab for Treatment of Critically Ill Patients With COVID-19

This drug is the first to control complement factor C5a, which is a protein that plays a significant but potentially harmful role in the body's immune response.



Amie Stephens, PharmD, MHA

Latest:

Pharmacists Bridge the Gaps in Care Transitions

From admission to discharge and beyond, pharmacists reduce medication errors, improve adherence, and prevent costly readmissions.



Edwin G. Ortiz-Munoz, PharmD Candidate 2026

Latest:

GLP-1 Boosters: Responding to Supplement Marketing Claims and Safety Questions

OTC GLP-1 boosters are marketed for weight loss, but pharmacists should help patients distinguish evidence-based care from supplement claims.


Mallory Murphy, MSN, PNP

Latest:

Help Pediatric Patients With Cerebral Palsy

For the common comorbidity of epilepsy, it is important to recognize and diagnose seizures as early as possible.


Rose McNulty

Latest:

Study Finds SARS-CoV-2 Booster Vaccination Lowers Infections, Hospitalizations, and Deaths in Nursing Homes

There are limited data on the efficacy of boosters for preventing infection and death in nursing home residents, but the findings suggest that boosters may have significantly reduced COVID-19–associated morbidity and mortality in this population.


Lindsey Mulrooney

Latest:

Study: Single Dose of Vaccine May Protect Older Adults from RSV-Related Infection

Findings from the ongoing Adult Respiratory Syncytial Virus phase 3 trial suggest RSVPreF3 OA vaccine is effective and safe for individuals aged 60 years and older.


Troy Trygstad, PharmD, PhD, MBA

Latest:

Vaccines Are Entering a Period of Simultaneous Expansion and Contraction

While vaccine research and approvals continue to break new ground, use and faith in them are faltering.


Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP

Latest:

COVID Vaccines for Children Are Becoming a Reality

Practitioners can help ensure that kids get these and all age-appropriate vaccinations before school starts in the fall.


Luke Halpern, Assistant Editor

Latest:

Expert: With New COVID-19 Vaccine Approvals, Pharmacists Should Remain Vigilant

Allison Hill, PharmD, RPh, emphasized that pharmacists must stay updated on ACIP and state-level guidance following HHS’s changes to COVID-19 vaccine authorizations.


Ron Panarotti

Latest:

The Expanding Power of Probiotics and Prebiotics in Overall Health

Probiotic and prebiotic supplements shape the gut microbiome and boost gastrointestinal health and immunity.


Alejandro Rivera-Rodríguez, PharmD, BCGP, CPPS, DPLA

Latest:

GLP-1 Boosters: Responding to Supplement Marketing Claims and Safety Questions

OTC GLP-1 boosters are marketed for weight loss, but pharmacists should help patients distinguish evidence-based care from supplement claims.


Ashley Gallagher, Associate Editor

Latest:

Oral Semaglutide Reduces Risk of MACE for Patients With Type 2 Diabetes

Oral semaglutide had a safe and well-tolerated profile for individuals with type 2 diabetes, which is in line with those previously reported for the drug in other trials.


Kennedy Ferruggia, Assistant Editor

Latest:

FDA Blocks Publication of COVID-19 and Shingles Vaccine Safety Studies: What Pharmacists Need to Know

The FDA halted or blocked publication of studies on COVID-19 and shingles vaccine safety—despite findings suggesting the vaccines are generally safe—due to concerns about the studies’ conclusions and scientific standards, raising debate about transparency and potential political influence in vaccine research.


Mike Hennessy Jr, Chairman and CEO

Latest:

OTC Guide: Thirty Years Strong

What began as a modest survey has grown into one of the most trusted barometers of frontline pharmaceutical expertise in the country.


Jennifer Glenn, MSN, PNP

Latest:

Help Pediatric Patients With Cerebral Palsy

For the common comorbidity of epilepsy, it is important to recognize and diagnose seizures as early as possible.


Alexandra Gerlach, Associate Editor

Latest:

Is Hantavirus Human-To-Human Transmissible?

Hantavirus is primarily spread from rodents to humans and is not generally considered human-to-human transmissible, though rare concern is being raised about specific strains like the Andes variant that may allow limited transmission under close contact, prompting pharmacists to focus on risk assessment, prevention, and patient education.


Sandra J. Grillo, MBA, RPh

Latest:

Moving the Needle From Vaccine Hesitancy to Vaccine Acceptance

Many factors contribute to vaccine skepticism, including trust, convenience, and fear.


Cheney Gazzam Baltz

Latest:

GLP-1 Boosters: Responding to Supplement Marketing Claims and Safety Questions

OTC GLP-1 boosters are marketed for weight loss, but pharmacists should help patients distinguish evidence-based care from supplement claims.


Kamila Dymala, PharmD, MBA, BCMTMS, PACS

Latest:

Caring for the Caregiver: Prioritizing Well-Being as a Pharmacist

The demands of the pharmacy profession—long hours, high stress, and emotional strain—can take a toll on pharmacists’ well-being.


Sky Medical Technology

Latest:

How Technology Can Improve Patient Outcomes While Reducing Financial Burdens

New interdisciplinary approaches to treatment include rebalancing the scales and exploring non-pharmaceutical interventions, such as dietary changes, exercise, and medical devices, to work alongside or instead of traditional care management techniques.


Stacey McCoy, PharmD, MS, BCPS

Latest:

Thinking Beyond Technology: Why a Holistic Approach Is a Better Way to Fight Drug Diversion

Although we have made strides in adopting technology to combat diversion, the uptake of advanced technology is slow and steady.



Jennifer Hofmann, DMSc, MS, PA-C, and Jean Covino, DHSc, MPA, PA-C

Latest:

What Is the Pharmacotherapy of GERD?

Treatment of gastroesophageal reflux disease requires a combination of lifestyle modifications and medications.

© 2026 MJH Life Sciences

All rights reserved.